Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Glioblastoma × Platinum × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 32 Uterine Cervical Neoplasms 18 Lung Neoplasms 18 Squamous Cell Carcinoma of Head and Neck 17 Small Cell Lung Carcinoma 16 Ovarian Neoplasms 12 Oropharyngeal Neoplasms 10 Urinary Bladder Neoplasms 9 Fallopian Tube Neoplasms 9 Carcinoma 9 Stomach Neoplasms 8 Mouth Neoplasms 8 Laryngeal Neoplasms 8 Hypopharyngeal Neoplasms 8 Breast Neoplasms 7 Nasopharyngeal Carcinoma 6 Mesothelioma, Malignant 6 Adenocarcinoma of Lung 6 Triple Negative Breast Neoplasms 5 Pancreatic Neoplasms 5 Medulloblastoma 5 Cholangiocarcinoma 5 Prostatic Neoplasms 4 Neuroblastoma 4 Ganglioneuroblastoma 4 Gallbladder Neoplasms 4 Esophageal Neoplasms 4 Brain Neoplasms 4 Vulvar Neoplasms 3 Urethral Neoplasms 3

Interventions

Temozolomide 362 Radiotherapy 181 Bevacizumab 142 Radiation 70 Magnetic Resonance Spectroscopy 60 Lomustine 43 pembrolizumab 37 Irinotecan 37 Carmustine 37 Surgical Procedures, Operative 34 Nivolumab 27 Carboplatin 25 Specimen Handling 23 Radiosurgery 23 Erlotinib Hydrochloride 23 Radiotherapy, Intensity-Modulated 20 Chemotherapy, Adjuvant 20 Aminolevulinic Acid 19 Cyclophosphamide 18 Drug Therapy 17 sargramostim 16 O(6)-benzylguanine 14 Radiotherapy, Conformal 13 Granulocyte-Macrophage Colony-Stimulating Factor 13 Everolimus 12 temsirolimus 11 Vorinostat 11 Sunitinib 11 Imatinib Mesylate 11 Etoposide 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07138001 2025-08-22

Phase 2 Clinical Trial of KH617

Chengdu Kanghong Pharmaceutical Group Co., Ltd.

Phase 2 Not yet recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡